Whitney Smith is a partner in the New York office and a member of K&L Gates’ corporate/M&A group. His practice focuses on domestic and cross-border M&A, joint venture, and private equity transactions, including negotiated mergers, auction bid processes, distressed asset sales, leveraged buyouts, and the acquisition and divestiture of divisions and subsidiaries. In addition to corporate transactions, Whitney advises public companies in connection with SEC reporting, corporate governance, and executive compensation matters. Whitney has represented clients in a wide range of industries, including life sciences, media services, technology, cannabis, financial services, manufacturing, and logistics, with a particular focus on the pharmaceutical industry.
In the pharmaceutical space, Whitney has represented clients in all types of business development and M&A transactions, from single product Co-Development and Commercialization Agreements to acquisitions and divestitures of manufacturing facilities and baskets of products to full company acquisitions and FTC-mandated product divestitures. A number of his transactions have involved acquisitions in India.
- “Arbitration As An Enforcement Solution In Cannabis Contracts,” Law360, 31 March 2022
- Contributing author, Securities Practice Guide (Lexis Nexis, 2014 editions)
- Mentioned, "Deal Diary: Skadden, BofA Advise Entegris on Fujifilm Deal," The Deal, 10 May 2023